Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies
- DOI
- 10.3389/fonc.2022.926289
- Published
- 2022-06-24
- Container
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2022.926289,
title = {Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies},
author = {Juan J. Mata-Molanes and Joseba Rebollo-Liceaga and Elena Mª Martínez-Navarro and Ramón González Manzano and Antonio Brugarolas and Manel Juan and Manuel Sureda},
year = {2022},
journal = {Frontiers in Oncology},
doi = {10.3389/fonc.2022.926289},
url = {https://doi.org/10.3389/fonc.2022.926289}
}RIS
TY - JOUR TI - Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies AU - Juan J. Mata-Molanes AU - Joseba Rebollo-Liceaga AU - Elena Mª Martínez-Navarro AU - Ramón González Manzano AU - Antonio Brugarolas AU - Manel Juan AU - Manuel Sureda PY - 2022 JO - Frontiers in Oncology DO - 10.3389/fonc.2022.926289 UR - https://doi.org/10.3389/fonc.2022.926289 ER -
APA
Mata-Molanes, J. J., Rebollo-Liceaga, J., Martínez-Navarro, E. M., Manzano, R. G., Brugarolas, A., Juan, M., & Sureda, M. (2022). Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies. Frontiers in Oncology. https://doi.org/10.3389/fonc.2022.926289
Source records
- crossref · retrieved 2026-09-26T10:57:32.663Z